Supplementary Materials and Methods from MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with &lt;i&gt;MTAP&lt;/i&gt;-Deleted Cancer